DocuSign, Inc. (NASDAQ:DOCU) Stake Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 3.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,709,807 shares of the company’s stock after purchasing an additional 50,440 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.85% of DocuSign worth $153,780,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of DOCU. Rhumbline Advisers increased its stake in shares of DocuSign by 118.8% during the 4th quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock worth $54,695,000 after purchasing an additional 330,136 shares during the last quarter. KBC Group NV lifted its position in DocuSign by 32.7% in the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock worth $138,067,000 after purchasing an additional 378,233 shares during the period. Jennison Associates LLC acquired a new position in DocuSign during the fourth quarter worth $12,897,000. Principal Financial Group Inc. lifted its position in DocuSign by 3,026.7% during the 4th quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock worth $49,179,000 after buying an additional 529,308 shares in the last quarter. Finally, Amundi grew its stake in shares of DocuSign by 565.8% during the fourth quarter. Amundi now owns 1,379,575 shares of the company’s stock valued at $123,486,000 after purchasing an additional 1,172,368 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 15th. The shares were sold at an average price of $76.09, for a total transaction of $608,720.00. Following the completion of the transaction, the chief financial officer now directly owns 86,156 shares in the company, valued at $6,555,610.04. This represents a 8.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now owns 8,270 shares of the company’s stock, valued at $722,880.70. This trade represents a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,851 shares of company stock worth $3,912,239. Company insiders own 1.01% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on DOCU shares. Wells Fargo & Company reduced their target price on shares of DocuSign from $73.00 to $65.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 22nd. Hsbc Global Res raised DocuSign from a “moderate sell” rating to a “hold” rating in a research note on Friday, April 11th. Wedbush reissued a “neutral” rating and issued a $100.00 price target on shares of DocuSign in a research note on Friday, March 14th. Jefferies Financial Group lowered their price objective on shares of DocuSign from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, March 31st. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a report on Thursday, April 17th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $92.46.

DocuSign Stock Down 2.2%

Shares of NASDAQ:DOCU opened at $84.61 on Friday. The stock has a market cap of $17.13 billion, a PE ratio of 17.45, a P/E/G ratio of 6.94 and a beta of 1.21. The business has a 50 day moving average of $81.76 and a 200-day moving average of $85.68. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.

DocuSign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to analysts’ expectations of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.76 EPS. Equities research analysts expect that DocuSign, Inc. will post 1.17 earnings per share for the current year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.